Product Name: IL9 Receptor antibody [33423.111]
Applications: ELISA, Neut, WB
Predicted Target Size:
Positive Controls:
Form Supplied:
Concentration:
Purification: Purified immunoglobulin
Full Name: interleukin 9 receptor
Background: Human Interleukin 9 (IL9) was first identified based on its proliferative activity on a human myeloid leukemic cell line. Human IL9 stimulates the proliferation of the human megakaryocytic leukemic cell line M07e. Human IL9 supports erythroid colony formation and synergizes with IL4 in the production of IgE and IgG. The interleukin 9 receptor is a member of the hematopoietin receptor superfamily. The cDNAs encoding mouse and human IL9 receptors have been isolated. The deduced mouse and human transmembrane proteins, sharing 53% amino acid sequence identity, contain 468 and 533 amino acid residues, respectively. A number of isoforms of IL9R, including a putative soluble form, have also been identified. The IL9 receptor is expressed in a variety of hematopoietic cells including T cells, neutrophils, mast cells, and macrophages.
Synonyms: IL9 R, IL9R, CD129
Cellular Localization:
CAS NO: 1217809-61-4
Product: PTACH
Host: Mouse
Clonality: Monoclonal
Isotype: IgG1
Immunogen: purified recombinant human soluble IL-9 receptor, expressed in Sf 21 insect cells.
Antigen Species: Human
Species Reactivity: Human
Conjugation: Unconjugated
Storage Buffer: PBS, 0.02% sodium azide
Storage Instruction: Keep as concentrated solution. For short-term storage, store at 4° C (up to 10 days). For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles.
Notes: For In vitro laboratory use only. Not for any clinical, therapeutic, or diagnostic use in humans or animals. Not for animal or human consumption.
Specificity: The antibody blocks the cell surface human IL-9 receptor mediated biological activities induced by recombinant human IL-9.
PubMed ID:http://www.ncbi.nlm.nih.gov/pubmed/26217309?dopt=Abstract
